ACRS
Aclaris Therapeutics, Inc.Company with tickers: ACRS
CIK
1557746
CUSIP
00461U105
Shares Outstanding
139,663,680
Website
https://www.aclaristx.com
13F Activity (30d)
84 filings
81 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2025-07-29 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-10-14 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2026-01-06 | — | |
| 8-K | 2026-01-12 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2026-03-10 | 2026-03-09 | |
| 8-K | 2026-03-11 | 2026-03-10 | |
| DEF 14A | 2026-04-23 | 2026-06-04 | |
| 8-K | 2026-04-28 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| 8-K | 2026-06-04 | — |
Showing 101–117 of 117 filings